Completed PHASE3 INTERVENTIONAL 2-arm NCT01392833

Steroids and Azathioprine in Advanced IgAN

Steroids and Azathioprine in Early and Advanced IgA Nephropathy: Amendments to a Prospective Randomised Multicenter Trial

Sponsor: A. Manzoni Hospital

Conditions Chronic Kidney Disease IgA Nephropathy

Interventions azathioprine methylprednisolone prednisone

Updated 5 times since 2017 Last updated: Jul 12, 2011 Started: Dec 31, 1999 Primary completion: Nov 30, 2006 Completion: Jan 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01392833, this PHASE3 trial focuses on Chronic Kidney Disease and IgA Nephropathy and remains completed. Sponsored by A. Manzoni Hospital, it has been updated 5 times since 1999, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Dec 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

A. Manzoni Hospital

Data source: A. Manzoni Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.